Avenue Therapeutics (NASDAQ:ATXI) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Avenue Therapeutics (ATXI) operate in?

Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Avenue Therapeutics Stock (NASDAQ: ATXI) stock price, news, charts, stock research, profile.

Open	$1.74
Close	$1.72
Volume / Avg.	19.71K / 45.98K
Day Range	$1.71 - $1.80
52 Wk Range	1.60 - 26.47
Market Cap	$3.68M
P/E Ratio	0.07
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	1.71%
Days to Cover	1.35

Recent News

Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Why Avenue Therapeutics (ATXI) Stock Is Falling Sharply

Avenue Therapeutics shares are trading lower by 20.7% during Monday's session. The company announced the exercise of warrants for $4.4 million in gross proceeds.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.74
Close	$1.72
Volume / Avg.	19.71K / 45.98K
Day Range	$1.71 - $1.80
52 Wk Range	1.60 - 26.47
Market Cap	$3.68M
P/E Ratio	0.07
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	1.71%
Days to Cover	1.35

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Avenue Therapeutics (ATXI) stock?

You can purchase shares of Avenue Therapeutics (NASDAQ:ATXI) through any online brokerage.

View our list of the best stock brokerages

Who are Avenue Therapeutics (ATXI) competitors?

Other companies in Avenue Therapeutics’s space includes: 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Sonoma Pharmaceuticals (NASDAQ:SNOA), Hepion Pharmaceuticals (NASDAQ:HEPA) and Redhill Biopharma (NASDAQ:RDHL).

What is the forecast, or price target, for Avenue Therapeutics (ATXI) stock?

Avenue Therapeutics has a consensus price target of $16.38.

What is the current price for Avenue Therapeutics (ATXI)?

The stock price for Avenue Therapeutics (NASDAQ: ATXI) is $1.79 last updated December 23, 2024 at 9:05 AM EST.

Does Avenue Therapeutics (ATXI) pay a dividend?

There are no upcoming dividends for Avenue Therapeutics.

When is Avenue Therapeutics (NASDAQ:ATXI) reporting earnings?

Avenue Therapeutics’s Q4 earnings are confirmed for Monday, March 17, 2025.

Is Avenue Therapeutics (ATXI) going to split?

There is no upcoming split for Avenue Therapeutics.

What sector and industry does Avenue Therapeutics (ATXI) operate in?

Avenue Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Avenue Therapeutics

Avenue Therapeutics (ATXI) Forecast